225 related articles for article (PubMed ID: 33758996)
1. Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence.
Bhat S; Adiga D; Shukla V; Guruprasad KP; Kabekkodu SP; Satyamoorthy K
Cell Biol Toxicol; 2022 Apr; 38(2):237-258. PubMed ID: 33758996
[TBL] [Abstract][Full Text] [Related]
2. DNA promoter methylation-dependent transcription of the double C2-like domain β (DOC2B) gene regulates tumor growth in human cervical cancer.
Kabekkodu SP; Bhat S; Radhakrishnan R; Aithal A; Mascarenhas R; Pandey D; Rai L; Kushtagi P; Mundyat GP; Satyamoorthy K
J Biol Chem; 2014 Apr; 289(15):10637-10649. PubMed ID: 24570007
[TBL] [Abstract][Full Text] [Related]
3. DOC2B is a negative regulator of Wnt/β-catenin signaling pathway in cervical cancer.
Adiga D; Bhat S; Chakrabarty S; Kabekkodu SP
Pharmacol Res; 2022 Jun; 180():106239. PubMed ID: 35500882
[TBL] [Abstract][Full Text] [Related]
4. DOC2B: a novel syntaxin-4 binding protein mediating insulin-regulated GLUT4 vesicle fusion in adipocytes.
Fukuda N; Emoto M; Nakamori Y; Taguchi A; Miyamoto S; Uraki S; Oka Y; Tanizawa Y
Diabetes; 2009 Feb; 58(2):377-84. PubMed ID: 19033398
[TBL] [Abstract][Full Text] [Related]
5. Doc2B acts as a calcium sensor for vesicle priming requiring synaptotagmin-1, Munc13-2 and SNAREs.
Houy S; Groffen AJ; Ziomkiewicz I; Verhage M; Pinheiro PS; Sørensen JB
Elife; 2017 Dec; 6():. PubMed ID: 29274147
[TBL] [Abstract][Full Text] [Related]
6. Double C-2 like domain beta (DOC2B) induces calcium dependent oxidative stress to promote lipotoxicity and mitochondrial dysfunction for its tumor suppressive function.
Adiga D; Bhat S; Shukla V; Shah HV; Kuthethur R; Chakrabarty S; Kabekkodu SP
Free Radic Biol Med; 2023 May; 201():1-13. PubMed ID: 36913987
[TBL] [Abstract][Full Text] [Related]
7. Doc2b synchronizes secretion from chromaffin cells by stimulating fast and inhibiting sustained release.
Pinheiro PS; de Wit H; Walter AM; Groffen AJ; Verhage M; Sørensen JB
J Neurosci; 2013 Oct; 33(42):16459-70. PubMed ID: 24133251
[TBL] [Abstract][Full Text] [Related]
8. DOC2B acts as a calcium switch and enhances vesicle fusion.
Friedrich R; Groffen AJ; Connell E; van Weering JR; Gutman O; Henis YI; Davletov B; Ashery U
J Neurosci; 2008 Jul; 28(27):6794-806. PubMed ID: 18596155
[TBL] [Abstract][Full Text] [Related]
9. Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity.
Ramalingam L; Oh E; Yoder SM; Brozinick JT; Kalwat MA; Groffen AJ; Verhage M; Thurmond DC
Diabetes; 2012 Oct; 61(10):2424-32. PubMed ID: 22698913
[TBL] [Abstract][Full Text] [Related]
10. Doc2b enrichment enhances glucose homeostasis in mice via potentiation of insulin secretion and peripheral insulin sensitivity.
Ramalingam L; Oh E; Thurmond DC
Diabetologia; 2014 Jul; 57(7):1476-84. PubMed ID: 24705606
[TBL] [Abstract][Full Text] [Related]
11. Doc2b promotes GLUT4 exocytosis by activating the SNARE-mediated fusion reaction in a calcium- and membrane bending-dependent manner.
Yu H; Rathore SS; Davis EM; Ouyang Y; Shen J
Mol Biol Cell; 2013 Apr; 24(8):1176-84. PubMed ID: 23427263
[TBL] [Abstract][Full Text] [Related]
12. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
[TBL] [Abstract][Full Text] [Related]
13. DOC2b is a SNARE regulator of glucose-stimulated delayed insulin secretion.
Miyazaki M; Emoto M; Fukuda N; Hatanaka M; Taguchi A; Miyamoto S; Tanizawa Y
Biochem Biophys Res Commun; 2009 Jul; 384(4):461-5. PubMed ID: 19410553
[TBL] [Abstract][Full Text] [Related]
14. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
[TBL] [Abstract][Full Text] [Related]
16. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.
Jia J; Zhang W; Liu JY; Chen G; Liu H; Zhong HY; Liu B; Cai Y; Zhang JL; Zhao YF
PLoS One; 2012; 7(12):e51549. PubMed ID: 23272116
[TBL] [Abstract][Full Text] [Related]
17. DOC2B, C2 domains, and calcium: A tale of intricate interactions.
Friedrich R; Yeheskel A; Ashery U
Mol Neurobiol; 2010 Feb; 41(1):42-51. PubMed ID: 20052564
[TBL] [Abstract][Full Text] [Related]
18. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
19. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
20. Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition.
Yu X; Liu Y; Yin L; Peng Y; Peng Y; Gao Y; Yuan B; Zhu Q; Cao T; Xie B; Sun L; Chen Y; Gong Z; Qiu Y; Fan X; Li X
Oncogene; 2019 Jan; 38(4):549-563. PubMed ID: 30158672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
